Venrock Healthcare Capital Partners III, L.P. (CIK 1738048) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-27). Recent activity: Sell KALV (174,485 shares), Sell KALV (160 shares), Sell KALV (21,386 shares), Sell KALV (15,417 shares), Sell KALV (3,183 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-27 | KalVista Pharmaceuticals, Inc. (KALV) | 10% Owner | Sell | 174,485 | $3.0M |
| 2026-03-27 | KalVista Pharmaceuticals, Inc. (KALV) | 10% Owner | Sell | 160 | $2,805 |
| 2026-03-27 | KalVista Pharmaceuticals, Inc. (KALV) | 10% Owner | Sell | 21,386 | $379,815 |
| 2026-03-27 | KalVista Pharmaceuticals, Inc. (KALV) | 10% Owner | Sell | 15,417 | $290,148 |
| 2026-03-27 | KalVista Pharmaceuticals, Inc. (KALV) | 10% Owner | Sell | 3,183 | $60,859 |
| 2025-04-11 | KalVista Pharmaceuticals, Inc. (KALV) | 10% Owner | Buy | 25,000 | $235,500 |
来源：SEC Form 4 申报文件 · 截至 2026-03-27